Aims Pulmonary hypertension (PH) in asymptomatic patients is a rare cause of sudden death. This study aims to determine the incidence of this entity and raise awareness among pathologists.
Methods We retrospectively investigated 44 cases of sudden unexpected death in relation to PH in patients not on antihypertensive therapy. This is the largest pathological study reported.
Results We report 44 cases of sudden death due to PH in which 28 (63.63%) were female and 16 (36.36%) were male, and the age range was from 5 days to 93 years old (mean age: 24±20). The majority had no clinical evidence of PH prior to death with none on therapy. The majority died at rest, 18 cases (40.90%), while 7 patients (15.90%) died following cardiac surgery and 7 patients (15.90%) during pregnancy or postpartum, 6 of whom had congenital heart disease. The cause of PH was recognised as congenital heart disease in 27 patients (61.36%), 14 of whom had simple congenital heart disease, such as atrial or ventricular septal defect,and 13 had complex congenital heart disease with associated atrial septal defect or ventricular septal defect. The remaining 17 patients (29.55%) suffered from primary PH due to plexiform arteriopathy, veno-occlusive disease and thromboembolic disease. Extensive sampling of the lungs is required to detect the lesions microscopically in these conditions.
Conclusions It is important that clinicians and pathologists be aware of the risk of sudden unexpected death in asymptomatic patients with PH, especially in those with congenital heart disease, after cardiac surgery or pregnancy.
- AUTOPSY PATHOLOGY
- VASCULAR DISEASE
- PULMONARY PATHOLOGY
Statistics from Altmetric.com
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Pulmonary hypertension (PH) is diagnosed when pulmonary artery pressure is above 25 mm Hg at rest and 30 mm Hg during exercise. It is a devastating, life-threatening disorder with no curative options, characterised by elevated pulmonary vascular resistance and secondary right ventricular failure. The aetiologies of pulmonary arterial hypertension (PAH) are multiple and its pathogenesis is complex.1 PH can develop in association with many different diseases and its presence is nearly always associated with reduced survival. The prognosis and management of PH is largely dependent upon its underlying aetiology and severity of disease. It can be primary or secondary.2 Regardless of aetiology, the final common pathway of PH is right heart failure and death. The average survival after diagnosis is <4 years. New therapy has led to increased survival. In a recent study, PH was the direct cause of death (right heart failure or sudden death) in 44% of patients; PH contributed to, but did not directly cause, death in 37 (44%) patients; and the death was not related to PH in the remaining cases (n=7; 8.3%). All these patients had been symptomatic and on treatment for their PH.3 Sudden death is very rare in patients with no prior symptoms, and a careful histological examination of the lungs is necessary to confirm the diagnosis. There have been previous reports describing sudden unexpected death from undiagnosed PH.4–6
We present 44 patients who died suddenly and had PH at autopsy without previous treatment. This is the largest pathological study reported. These cases raise awareness of PH as a cause of sudden unexpected death and the importance of lung histology at autopsy in these circumstances.7
The Cardiac Risk in the Young (CRY) Cardiovascular pathology unit at St George's Medical School, London, acts as a specialist tertiary cardiac pathology centre for sudden cardiac death (SCD) in the UK. We defined SCD as an unexpected death occurring within 24 h of onset of symptoms. We found 44 cases diagnosed with PH. The diagnosis of PH was made in all these cases due to histological changes of widespread and severe PH in pulmonary arteries with medial hypertrophy, intimal fibrosis and occlusion with plexiform lesions. These were considered severe enough to be linked to the death. In those with cardiac conditions at autopsy, there were no new cardiac findings at autopsy to explain the sudden death which is presumed to be due to a cardiac arrhythmia in most cases. The patient's age, sex, circumstances of death and past medical history were obtained from the referring pathologist/coroner. All patients underwent toxicology screen which was negative in all 44 cases. The data of the postmortem clinical and histopathological findings in each case were collected prospectively. Pathological analysis of all lungs was performed by MNS with the consent of the coroner and the next of kin, according to the specific guidlines.5
Characteristics of the population were described as means, SDs (±SD) for continuous variables and counts with presentations for all variables.
Forty-four cases of sudden death due to PH from the database, from which 28 (63.63%) were female and 16 (36.36%) were male. The average age was 24±20, and the age range was from 5 days to 93 years old. All had been well prior to death with none on therapy for PH.
Circumstances of death
The circumstances of death reported from the referring coroner include the following: majority died at rest, 18/44 (40.90%). Death occurred unexpectedly postoperatively in 7 patients, all following cardiac surgery (15.90%), who had been well with no cardiac dysfunction or arrhythmias, and during pregnancy or postpartum in 7 patients, 6 of whom had congenital heart disease (CHD) (15.90%). Circumstances were unknown in 12 patients (27.27%).
All had right ventricular hypertrophy at autopsy with enlarged pulmonary artery branches. Those with CHD had appropriate cardiac findings with or without surgery with no surgical complications found in those who had recent surgery. In all these congenital cardiac cases, the lungs were macroscopically normal. In those with primary PH with or without associated conditions, the lungs were macroscopically normal, and usually 2 sections from each lung lobe were taken at autopsy with H&E staining, as well as Elastin van Gieson, to visualise the blood vessels. In arterio-venous malformation case, a large malformation was noted on the surface of the left lower lobe of the lung with several underlying dilated channels around it. In thromboemboli disease, there were obstructive lesions in the smaller lobar vessels filled with pale firm tissue in all lobes with focal scars on the pleural surface of the lungs in keeping with old infarcts. There were no fresh thrombi in the pulmonary arterial branches.
Causes of PH
Congenital heart disease
The most common cause of PH in our study was CHD (n=27 or 61.36%), with the majority (n=22 or 81.48%) being ≤35 years old, and the age range from 5 days to 56 years old. Simple CHD was identified in 14 patients (51.85%), four had atrial septal defect, four ventricular septal defect, one aortic atresia with ventricular septal defect, four patent ductus arteriosus and one atrioventricular septal defect. In 7 cases, the patients had correction of the defect; in 7, no surgery was done due to diagnosis of Eisenmengers (Intracardiac shunt that reverses to a right-to-left shunt due to irreversible PH). Complex CHD with associated atrial septal defect or ventricular septal defect was seen in 13 patients (48.15%). All these had surgery in the past, with 3 having Eisenmenger’s syndrome. All these cases had plexiform lesions in the lungs associated with intimal obstruction and medial hypertrophy of the blood vessels at autopsy (figure 1A). The surgery for their CHD had no complications at autopsy which would have explained their sudden unexpected death.
Primary PH and those with associated causes
There were 17 cases (29.55%) of primary PH due to plexiform arteriopathy (7), (one of whom was pregnant) veno-occlusive disease (6) (figure 1B) and thromboembolic disease (1), (figure 1C) antithrombin-3 deficiency associated with scleroderma (1), pulmonary arterio-venous malformation (1) and giant cell vasculitis of pulmonary arteries with no vasculitis elsewhere (1) (figure 1D).
This study highlights PH detected in the lung at autopsy in cases of sudden unexpected death. This is an important finding as this will make a valuable contribution in explaining the sudden death. The pathologist must be aware of occult PH as a contributing cause of sudden unexpected death in a variety of age groups6 and especially in patients with CHD. Cardiac arrhythmias are important contributors to morbidity and mortality in patients with PH.8 The only way to make the diagnosis rests with a carefully performed autopsy and histological sampling of the lungs. Right ventricular hypertrophy and dilatation will usually be the first clue at autopsy. Careful scrutiny of many histological sections, usually 2 from each lobe of lung with particular attention to vascular structures is necessary. Plexiform lesions may be obscured by pulmonary oedema and congestion and will be missed if there is only a cursory review of the material. Vascular changes can be notoriously heterogeneous and variable throughout the lung in PH.9 One needs to look carefully especially in the smaller arterioles and preacinar arterioles for the classic evidence of medial hypertrophy, intimal thickening, blocked vessels and outgrowth of plexiform vein-like lesions around the blocked vessels with or without fibrinoid necrosis in the blocked vessel walls. Significant medial wall abnormalities are also present in the pulmonary trunk including fibrosis, atypical elastic pattern, cystic medial degeneration and atheroma.10
Pulmonary vascular disease in adults with CHD and especially its extreme expression, the Eisenmenger syndrome, can lead to sudden death,11 often in adulthood.12 Arrhythmias are frequent late sequelae in patients with Eisenmenger physiology. In the series reported by Daliento et al,12a 42% of patients with Eisenmenger had supraventricular arrhythmias on routine ECG or 24 h Holter monitoring during long-term follow-up.13 In patients who experienced sudden death, no symptoms of heart failure, history of arrhythmias or features of haemodynamic abnormalities were observed in 15% of cases.14
These arrhythmias combined with the congenital abnormalities in the heart make a sudden arrhythmic death likely. The pathologist must be aware that despite surgery for CHD, vascular changes in the lung persist and progress over the years leading to right ventricular hypertrophy and dilatation which will make a significant contribution to the death. The heart at autopsy will show no surgical complications and it is essential to take histological samples of the lungs. Adult cardiology is faced with a new challenging patient population. Since only a few congenital heart defects can be cured, regular follow-up during adult life is of major importance. Despite optimal treatment, the patients will develop long-term complications, such as arrhythmias, sudden death, PH and heart failure. Acute complications, such as fatal arrhythmias, aortic dissection or rupture, endocarditis, cerebral events due to embolism, bleeding or abscesses, and pulmonary embolism or bleeding must be looked for an autopsy.15 Deaths following surgery in CHD include low output failure as most common, but PH and SCD are also prominent.16
This study also emphasises death in pregnancy and following delivery with PH. Pregnancy with CHD and PH is associated with a markedly increased risk of adverse cardiovascular events and death for delivery and in the postpartum period.17–20 PAH, including Eisenmenger syndrome, has a risk of mortality in pregnancy of 10%–40%.21 Again pathologists dealing with maternal deaths need to be aware of this and sample the lungs. Primary pulmonary hypertension (PPH) may be a cause of sudden unexpected death with few, if any, earlier signs or symptoms, and once the autopsy diagnosis of PPH is established the pathologist must be aware that the entity may be familiar, and the family physician and surviving relatives should be informed.4 In these cases, the direct cause of death may be the vascular changes in the lungs combined with right ventricular hypertrophy and dilatation with terminal cardiac arrhythmia. The histological changes in veno-occlusive disease, chronic thromboembolic disease, antiphospholipid syndrome, hypertension associated with arterio-venous malformation and vasculitis are well described and the pathologist needs to be aware of these changes when the lungs are being examined. A trichrome stain is vital to highlight vascular changes in both arteries and veins.22
Left main coronary artery compression syndrome, pulmonary artery dissection, pulmonary artery rupture and severe haemoptysis are reported as complications leading to sudden death encountered more often in patients with PH.23 ,24 We had none of these complications in our series.
This study highlights the value of a full autopsy with histology in sudden unexpected death as in children25; the autopsy can be valuable in adults with and without CHD, postcardiac surgery and in maternal deaths. The message is, always take lung histology, which may explain the sudden death when cardiac congenital lesions are stable with superadded right-sided cardiac hypertrophy and dilatation.
Take home messages
Pulmonary hypertension is common in congenital heart disease and may contribute to sudden unexpected death. Patients may be asymptomatic clinically prior to death.
Always take lung histology. In primary and secondary pulmonary hypertension, the lungs may be macroscopically normal.
Right ventricular hypertrophy and dilation point at autopsy to pulmonary hypertension.
The risk of sudden unexpected death in asymptomatic patients with pulmonary hypertension is higher in those with congenital heart disease, after cardiac surgery or pregnancy.
Contributors MNS: conceived the review question, developed the protocol and performed part of writing or editing of the protocol and review. MNS: made an intellectual contribution to the review, and approved the final version and review prior to submission. DK: conceived the review question, developed the protocol and review, coordinated the protocol and review development, and completed the first draft of the protocol and review. DK: made an intellectual contribution to the review, and approved the final version of the review prior to submission. MNS: conceived the statistical analysis protocol and reviewed all of the statistical analysis prior to submission. Both authors are guarantors of the review.
Funding UK based charity – Cardiac Risk in the Young (CRY). Grant number 63529.
Competing interests None.
Patient consent Obtained.
Provenance and peer review Not commissioned; externally peer reviewed.